Predicate assessment
Review intended use, technological characteristics and relevant FDA-cleared devices.
Medical device regulatory services
We help emerging device companies identify potential predicates, establish evidence requirements and assemble submission documentation while their engineering teams focus on development.
Discuss your technology →Review intended use, technological characteristics and relevant FDA-cleared devices.
Map substantial equivalence questions, testing gaps and potential Pre-Submission topics.
Coordinate documentation, eSTAR assembly and responses to FDA requests, within an agreed scope.
Getting started
Share your technology and development objectives. We will define a practical initial scope and deliverables before beginning work.
Contact BioticaBio →Illustrative regulatory assessment
Independent example, not a client engagement or a determination of substantial equivalence.
Dental regeneration · K251062
Class II resorbable collagen barrier membrane for guided bone and tissue regeneration. FDA product code NPL.
FDA 510(k) summary →Evidence strategy
Assess intended use, barrier performance, degradation, biocompatibility and mechanical properties against relevant cleared devices. A synthetic material may require a different predicate or regulatory strategy; the collagen device is a screening precedent only.